Atlas Trials

Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)

Clinical trial NCT01162941 · UNKNOWN

Trial details

NCT number
NCT01162941
Sponsor
Cooperative Study Group A for Hematology
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Thrombocytopenia
Start date
2010-02-01
Primary completion
2011-07-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.